# GENPRIME INC: Form D filing

GENPRIME INC, a biotechnology company in Spokane, WA, filed a Form D with the SEC in 2013. The latest, on January 10, 2013, reports $160,000 sold of a $160,000 offering to 6 investors.

Find out what GENPRIME INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20GENPRIME%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=GENPRIME%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fgenprime-inc-1083845)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20GENPRIME%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=GENPRIME%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fgenprime-inc-1083845)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Washington](https://specstream.ai/data/form-d/state/washington): 1,095 rows, by operating companies, filed since November 1, 2024, $54.75, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/washington
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 157 SOUTH HOWARD STREET, SUITE 605, Spokane, WA, 99021
- Phone: (509) 624-9855
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Washington
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1083845

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 10, 2013 | New notice | $160,000 | $160,000 | $0 | 6 | Jan 2, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1083845/000108384513000002/0001083845-13-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| TOM BUCK TIFFANY | Director |  |
| TOM BUCK SIMPSON | Director |  |
| J. BUCK SOMES | Executive Officer, Director |  |
| DARBY BUCK MCLEAN | Executive Officer |  |
| STEPHEN BUCK MCGREW | Director |  |
| BASSEM BUCK BEJJANI | Director |  |
| RICK BUCK BLAKE | Director |  |
| JOHN BUCK PARISEAU | Director |  |
| JOHNNY BUCK HUMPHREYS | Executive Officer, Director |  |

## Other biotechnology companies in Washington that filed recently

- [Key Proteo, Inc.](https://specstream.ai/data/form-d/company/key-proteo-inc-1977784) $2.3 million · Oct 23, 2026
- [Inmedix, Inc.](https://specstream.ai/data/form-d/company/inmedix-inc-1851853) $4 million · Oct 22, 2026
- [Q-Immune, Inc.](https://specstream.ai/data/form-d/company/q-immune-inc-2155816) $25,000 · Sep 28, 2026
- [Hexamer Therapeutics, Inc](https://specstream.ai/data/form-d/company/hexamer-therapeutics-inc-1797915) $500,000 · Sep 15, 2026
- [MalarVx, Inc.](https://specstream.ai/data/form-d/company/malarvx-inc-1559688) $125,000 · Aug 25, 2026
- [Strella Biotechnology, Inc.](https://specstream.ai/data/form-d/company/strella-biotechnology-inc-1810011) $1.8 million · Aug 14, 2026

[Every Form D from the week of Jan 7, 2013](https://specstream.ai/data/form-d/week/2013-01-07) · [All recent filings in Washington](https://specstream.ai/data/form-d/state/washington) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what GENPRIME INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).